Using Group Metacognitive Therapy in Cardiac Rehabilitation
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
This study is testing whether adding group Metacognitive Therapy to cardiac rehabilitation can help heart disease patients manage anxiety and depression better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Manchester Academic / other |
| Locations | 1 site (Manchester) |
| Trial ID | NCT05956912 on ClinicalTrials.gov |
What this trial studies
This study focuses on implementing group Metacognitive Therapy (MCT) within cardiac rehabilitation services to address common issues of anxiety and depression among heart disease patients. The approach builds on previous findings that MCT can improve mental health outcomes when integrated into cardiac rehabilitation. The study will establish beacon sites for delivering MCT and will pilot-test enhancements to the national audit of cardiac rehabilitation data to include MCT-related metrics. This will allow for a thorough evaluation of the implementation process and its effectiveness.
Who should consider this trial
Good fit: Ideal candidates for this study are patients attending cardiac rehabilitation who meet the NICE recommendations for acute coronary syndrome and heart failure.
Not a fit: Patients who are not undergoing cardiac rehabilitation or do not meet the specified clinical criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the mental health and overall quality of life for patients undergoing cardiac rehabilitation.
How similar studies have performed: Previous studies have shown that integrating psychological therapies like MCT into cardiac rehabilitation can lead to improved outcomes, suggesting a promising avenue for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Qualitative Inclusion Criteria: All CR staff must meet the following inclusion criteria to be eligible: 1. Be a healthcare professional working with cardiac rehabilitation services being trained to deliver group-MCT 2. Be a healthcare professional working with cardiac rehabilitation or be a professional working at the commissioner level 3. Minimum of 18 years old 4. Competent level of English Language skills (able to read, understand and complete interviews in English). Exclusion Criteria: 1. Below 18 years of age 2. Not a healthcare professional or professional working at the commissioner level 3. Does not have a competent level of English language skills Audit inclusion criteria: All patients attending CR who meet the NICE recommendations for acute coronary syndrome (NG185) and heart failure (NG106) will be offered group MCT as part of routine CR.
Where this trial is running
Manchester
- Manchester University NHS Foundation Trust — Manchester, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Adrian Wells, PhD — University of Manchester
- Study coordinator: Adrian Wells, PhD
- Email: adrian.wells@manchester.ac.uk
- Phone: 01612765399
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.